Table 4.
Hematological variables and plasma cholesterol and triglycerides concentrations in lung cancer patients before and after radiotherapy.
| Variable * | Control Group | Lung Cancer Before Radiotherapy |
Lung Cancer After Radiotherapy |
|---|---|---|---|
| Hemoglobin (g/dL) | 14.9 (13.9–15.2) | 13.5 (11.0–13.9) c | 12.0 (11.3–13.1) c |
| Platelets (×109/L) | 277.0 (230.5–301.5) | 293.5 (241.0–357.0) | 175.0 (138.5–202.0) c,d |
| Total-cholesterol (mg/dL) | 155.9 (140.2–172.8) | 154.4 (135.6–177.0) | 161.8 (139.9–178.9) |
| VLDL-cholesterol (mg/dL) | 12.1 (8.6–16.7) | 18.0 (13.6–21.7) b | 15.9 (10.3–20.3) |
| IDL-cholesterol (mg/dL) | 7.3 (4.9–9.9) | 8.9 (7.3–10.0) a | 10.0 (7.3–11.2) b |
| LDL-cholesterol (mg/dL) | 89.3 (80.3–100.5) | 88.1 (68.9–99.4) | 92.6 (69.3–106.6) |
| HDL-cholesterol (mg/dL) | 43.4 (38.1–51.8) | 43.6 (34.3–52.1) | 47.1 (38.5–49.3) |
| Total-triglycerides (mg/dL) | 69.3 (49.5–82.2) | 97.3 (77.2–122.9) c | 94.0 (69.7–104.5) c |
| VLDL-triglycerides (mg/dL) | 38.1 (29.4–49.3) | 64.0 (41.1–78.1) c | 60.3 (44.2–69.6) c |
| IDL-triglycerides (mg/dL) | 6.8 (4.9–8.3) | 9.4 (7.7–10.2) c | 9.8 (7.4–11.0) c |
| LDL-triglycerides (mg/dL) | 8.8 (6.5–11.2) | 11.6 (8.6–14.7) b | 11.0 (8.7–14.9) b |
| HDL-triglycerides (mg/dL) | 11.3 (8.7–15.3) | 14.3 (11.8–17.9) b | 13.7 (11.9–14.9) |
* Results are shown as medians and interquartile ranges (in parenthesis). HDL: high-density lipoproteins; IDL: intermediate-density lipoproteins; LDL: low-density lipoproteins; VLDL: very-low-density lipoproteins. a p < 0.05, b p < 0.01, c p < 0.001, with respect to the control group; d p < 0.001, with respect to before radiotherapy, by the Mann-Whitney U-test.